Peter Bauer is a medical device executive with three decades of experience advancing innovation in cardiology and heart failure management. His work spans implantable therapeutic devices and non-invasive cardiac diagnostics, with a focus on improving patient outcomes and quality of life.
Peter has held senior leadership roles at BIOTRONIK and Inovise Medical, bringing experience in both established medical device companies and innovative startups. At Inovise, he helped position the company as an international pioneer in non-invasive cardiac monitoring. His expertise encompasses business development, operations, clinical studies, product development, and early-stage commercialization.
As Chief Executive Officer of VisCardia, Inc., Peter leads the company’s strategy and operations, advancing a novel therapeutic approach for heart failure patients who remain symptomatic despite guideline-directed medical therapy. Under his leadership, VisCardia is advancing its technology toward commercialization and pursuing a $10 billion market opportunity.